Relation of Preprocedural Statin Therapy to In-Hospital Procedural Complications Following Percutaneous Coronary Interventions in Patients With Hyperlipidemia

American Journal of Cardiology

Volumn 98, Issue 3, 2006, Pages 325-330

  Singh, Mandeep ^a   Lennon, Ryan J ^a   Roger, Veronique L ^a   Rihal, Charanjit S ^a   Halligan, Sean ^a   Lerman, Amir ^a   Yang, Eric ^a   Holmes Jr , David R ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; REVASCULARIZATION; RISK ASSESSMENT; SURVIVAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHOLESTEROL; CORONARY ANGIOGRAPHY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MALE; MYOCARDIAL ISCHEMIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33745950516     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.02.036     Document Type: Article

References (25)

1. Singh M., Lennon R.J., Holmes Jr. D.R., Bell M.R., and Rihal C.S. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol 40 (2002) 387-393
2. Resnic F.S., Ohno-Machado L., Selwyn A., Simon D.I., and Popma J.J. Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention. Am J Cardiol 88 (2001) 5-9
3. Moscucci M., Kline-Rogers E., Share D., O'Donnell M., Maxwell-Eward A., Meengs W.L., Kraft P., DeFranco A.C., Chambers J.L., Patel K., et al. Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions. Circulation 104 (2001) 263-268
4. Kimmel S.E., Berlin J.A., Strom B.L., Laskey W.K., and The Registry Committee of the Society for Cardiac Angiography and Interventions. Development and validation of simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. J Am Coll Cardiol 26 (1995) 931-938
5. Ellis S.G., Weintraub W., Holmes D., Shaw R., Block P.C., and King III S.B. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation 95 (1997) 2479-2484
6. Shaw R.E., Anderson H.V., Brindis R.G., Krone R.J., Klein L.W., McKay C.R., Block P.C., Shaw L.J., Hewitt K., and Weintraub W.S. Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience. 1998-2000. J Am Coll Cardiol 39 (2002) 1104-1112
7. Smith Jr. S.C., Dove J.T., Jacobs A.K., Kennedy J.W., Kereiakes D., Kern M.J., Kuntz R.E., Popma J.J., Schaff H.V., Williams D.O., et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 37 (2001) 2215-2239
8. Block P.C., Peterson E.D., Krone R., Kesler K., Hannan E., O'Connor G.T., Detre K., and Peterson E.C. Identification of variables needed to risk adjust outcomes of coronary interventions. evidence-based guidelines for efficient data collection. J Am Coll Cardiol 32 (1998) 275-282
9. Chan A.W., Bhatt D.L., Chew D.P., Quinn M.J., Moliterno D.J., Topol E.J., and Ellis S.G. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation 105 (2002) 691-696
10. Chan A.W., Bhatt D.L., Chew D.P., Reginelli J., Schneider J.P., Topol E.J., and Ellis S.G. Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation 107 (2003) 1750-1756
11. Chang S.M., Yazbek N., and Lakkis N.M. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome. Catheter Cardiovasc Interv 62 (2004) 193-197
12. Walter D.H., Fichtlscherer S., Britten M.B., Auch-Schwelk W., Schachinger V., and Zeiher A.M. Benefits of immediate initiation of statin therapy following successful coronary stent implantation in patients with stable and unstable angina pectoris and Q-wave acute myocardial infarction. Am J Cardiol 89 (2002) 1-6
13. Serruys P.W., de Feyter P., Macaya C., Kokott N., Puel J., Vrolix M., Branzi A., Bertolami M.C., Jackson G., Strauss B., and Meier B. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention. a randomized controlled trial. JAMA 287 (2002) 3215-3222
14. Mulukutla S.R., Marroquin O.C., Smith C., Varghese R., Anderson W.D., Lee J.S., Cohen H.A., Counihan P.J., Lee A.B., Gulati V., and McNamara D. Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury. Am J Cardiol 94 (2004) 1363-1366
15. Ellis S.G., Chew D., Chan A., Whitlow P.L., Schneider J.P., and Topol E.J. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation 106 (2002) 1205-1210
16. Ellis S.G., Vandormael M.G., Cowley M.J., DiSciascio G., Deligonul U., Topol E.J., Bulle T.M., and Multivessel Angioplasty Prognosis Study Group. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Circulation 82 (1990) 1193-1202
17. O'Connor G.T., Malenka D.J., Quinton H., Robb J.F., Kellett Jr. M.A., Shubrooks S., Bradley W.A., Hearne M.J., Watkins M.W., Wennberg D.E., et al., Northern New England Cardiovascular Disease Study Group. Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. J Am Coll Cardiol 34 (1999) 681-691
18. Qureshi M.A., Safian R.D., Grines C.L., Goldstein J.A., Westveer D.C., Glazier S., Balasubramanian M., and O'Neill W.W. Simplified scoring system for predicting mortality after percutaneous coronary intervention. J Am Coll Cardiol 42 (2003) 1890-1895
19. Brescianini S., Maggi S., Farchi G., Mariotti S., Di Carlo A., Baldereschi M., and Inzitari D. Low total cholesterol and increased risk of dying. are low levels clinical warning signs in the elderly? Results from the Italian Longitudinal Study on Aging. J Am Geriatr Soc 51 (2003) 991-996
20. Aronow H.D., Topol E.J., Roe M.T., Houghtaling P.L., Wolski K.E., Lincoff A.M., Harrington R.A., Califf R.M., Ohman E.M., Kleiman N.S., et al. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes. an observational study. Lancet 357 (2001) 1063-1068
21. Schwartz G.G., Olsson A.G., Ezekowitz M.D., Ganz P., Oliver M.F., Waters D., Zeiher A., Chaitman B.R., Leslie S., and Stern T. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
22. Gottsauner-Wolf M., Zasmeta G., Hornykewycz S., Nikfardjam M., Stepan E., Wexberg P., Zorn G., Glogar D., Probst P., Maurer G., and Huber K. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 21 (2000) 1152-1158
23. Lindahl B., Toss H., Siegbahn A., Venge P., and Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 343 (2000) 1139-1147
24. Muhlestein J.B., Horne B.D., Carlquist J.F., Madsen T.E., Bair T.L., Pearson R.R., and Anderson J.L. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 102 (2000) 1917-1923
25. Horne B.D., Muhlestein J.B., Carlquist J.F., Bair T.L., Madsen T.E., Hart N.I., and Anderson J.L. Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. J Am Coll Cardiol 36 (2000) 1774-1780